Blue Trust Inc’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Blue Trust Inc’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-119	Closed	-$15.7K	–	2631
2025 Q1	$15.7K	Hold	119	–	–	﹤0.01%	1724
2024 Q4	$9.94K	Buy	119 +77	+183%	+$6.33K	﹤0.01%	1875
2024 Q3	$2.88K	Buy	42 +9	+27%	+$676	﹤0.01%	2512
2024 Q2	$2.28K	Buy	+33	New	+$2.29K	﹤0.01%	2414
2024 Q1	–	Sell	-7	Closed	–	–	2767
2023 Q4	$0	Buy	+7	New	+$403	﹤0.01%	2725
2023 Q3	–	Sell	-4	Closed	–	–	2332
2023 Q2	$0	Hold	4	–	–	﹤0.01%	2602
2023 Q1	$0	Buy	+4	New	+$193	﹤0.01%	2686

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Blue Trust Inc's ITCI Position: Q2 2025 in Review

Blue Trust Inc sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 119 shares — an estimated $15.7K sold.

Blue Trust Inc first reported a position in ITCI in Q1 2023 and held it in 7 quarters. The position peaked at $15.7K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Blue Trust Inc reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Blue Trust Inc sold 119 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $15.7K.
Blue Trust Inc first reported a position in Intra-Cellular Therapies Inc. in Q1 2023 and held it in 7 quarters.
Blue Trust Inc's Intra-Cellular Therapies Inc. position peaked at $15.7K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Blue Trust Inc's 13F filing for Q2 2025, filed 24 Jul 2025.